RxDoctor Payments Data

Liying Han, MD

Anatomic Pathology & Clinical Pathology · Valhalla, NYNPI 1750502589

Payments from drug & device makers

$80in general payments, 2019–2025

Across 3 payments — averaging $26.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Blueprint Medicines Corporation$32
  • AstraZeneca$24
  • Merck$24

What the payments were for

  • Food & beverage$80100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Blueprint Medicines Corporation1$32
AstraZeneca1$24
Merck1$24

How this compares

$80 in reported general payments places this provider in the 45th percentile of 468 anatomic pathology & clinical pathology providers in New York.

See all anatomic pathology & clinical pathology providers in New York

Medicare billing

Part B allowed, 2024
$291,537
Medicare patients
915
Services billed
9,309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Valhalla

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →